FDA 483 - Shanghai Henlius Biologics Co., Ltd. - March 11, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Shanghai Henlius Biologics Co., Ltd. in Songjiang District, Shanghai, China, revealed inadequate quality unit oversight. Specifically, the firm's visual inspection process for drug product samples was found to be inadequate, and deficiencies were noted in the qualification and requalification studies of HEPA filters for the ABS filling line. These observations highlight concerns with the firm's quality control and environmental monitoring practices.
ID · d6806e72-e2ac-48ef-93a4-336d3aff995b